Thirty psychedelic researchers identified critical gaps in knowledge about harms from psychedelic use, including how to define those harms, predict them, and treat them effectively. They recommend better online information, peer support groups, affordable therapy, and psychiatric consultation for people experiencing post-psychedelic difficulties. The researchers also call for improved funding for a psychedelic safety net, suggesting that psychedelic philanthropists, investors, and companies commit 1% of their investment to support safety measures such as research and support services. The article outlines practical steps to make the field of psychedelic medicine safer.
Ten individuals aged 15–25 who experienced challenging psychedelic episodes with difficulties lasting longer than a day described emotional, cognitive, and relational struggles. They used diverse strategies to make sense of their experiences, highlighting the importance of preparation, supportive relationships, and developmentally appropriate integration. The findings suggest that age-specific harm reduction and integration services, along with improved safety protocols and psychoeducation, could help reduce long-term distress and support more ethical psychedelic use.